ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Cabozantinib impurity 1DYH
Cabozantinib impurity 1DYH
![Cabozantinib impurity 1DYH Structure](CAS/20200611/GIF/1621681-63-7.gif)
- CAS No.
- 1621681-63-7
- Chemical Name:
- Cabozantinib impurity 1DYH
- Synonyms
- Cabozantinib Impurity 04;Cabozantinib impurity 1DYH;N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine;4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide ;N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
- CBNumber:
- CB15581295
- Molecular Formula:
- C28H24FN3O6
- Molecular Weight:
- 517.51
- MOL File:
- 1621681-63-7.mol
- Modify Date:
- 2022/12/21 16:56:50
Cabozantinib impurity 1DYH Chemical Properties,Uses,Production
Uses
Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.
Cabozantinib impurity 1DYH Preparation Products And Raw materials
Raw materials
Preparation Products
Cabozantinib impurity 1DYH Suppliers
Global( 29)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
CLEARSYNTH LABS LTD. | +91-22-45045900 | Hyderabad, India | 6351 | 58 | Inquiry |
Pharmaffiliates Analytics and Synthetics P. Ltd | +91-172-5066494 | Haryana, India | 6773 | 58 | Inquiry |
Pharma Affiliates | 172-5066494 | Haryana, India | 6761 | 58 | Inquiry |
Wuhan Jingkang en Biomedical Technology Co., Ltd | +8613720134139 | China | 5225 | 58 | Inquiry |
LangFangshi Zekang Pharma Tech CO.,Itd. | 0316-2883536 19333636468 | China | 1321 | 58 | Inquiry |
Hubei De'ao Chemical Research Pharmaceutical Technology Co., Ltd | 18502726233; 18502726233 | China | 9808 | 58 | Inquiry |
Shanghai Hao Zhun Biological Technology Co., Ltd. | 15800340161 | CHINA | 6846 | 58 | Inquiry |
Foshan Treasure Biotechnology Co., Ltd | 0757-85921206 18520245316 | China | 12664 | 58 | Inquiry |
Nanjing Shanyao Kangcheng biomedical Co., Ltd. | 15722982350 | China | 523 | 58 | Inquiry |
Shenzhen Roark Pharma-Tec Co., Ltd. | 13128912434 | China | 2579 | 58 | Inquiry |
1621681-63-7(Cabozantinib impurity 1DYH)Related Search:
Cabozantinib Impurity EXA
1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid
Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]-
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-
chevron_left
1of4
chevron_right
N-[4-[(6,7-Dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide
Cabozantinib impurity 1DYH
1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-1-oxido-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-
4-(4-(1-((4-fluorophenyl)carbamoyl)cyclopropane-1-carboxamido)phenoxy)-6,7-dimethoxyquinoline 1-oxide
N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-6,7-dimethoxyquinolin-4-amine
Cabozantinib Impurity 04
1621681-63-7
C28H24FN3O6